# Market Research - Acceptability Study for New MCT Fat Products

> **NCT04309214** · NA · COMPLETED · sponsor: **Dr. Schär AG / SPA** · enrollment: 12 (actual)

## Conditions studied

- Ketosis
- Epilepsy
- Fatty Acid Oxidation Disorder
- Malabsorption
- Ketogenic Diet
- Medium Chain Triglycerides

## Interventions

- **DIETARY_SUPPLEMENT:** MCT fats

## Key facts

- **NCT ID:** NCT04309214
- **Lead sponsor:** Dr. Schär AG / SPA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2019-01-21
- **Final completion:** 2019-01-21
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309214, "Market Research - Acceptability Study for New MCT Fat Products". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04309214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*